The REVTORPYK Support Services Program is available to help you with the cost of your REVTORPYK treatment.*
Call 877-4-CELCUITY (877-423-5284)
Monday through Friday, 8:00 am to 8:00 pm ET
REVTORPYK may cause serious side effects, including:
Mouth sores (stomatitis). REVTORPYK can cause severe mouth sores, including mouth ulcers. Your healthcare provider will prescribe an alcohol-free, steroid-containing mouthwash to help prevent and treat mouth sores. Use as instructed by your healthcare provider. Do not eat or drink for at least 1 hour after using the steroid-containing mouthwash.
Tell your healthcare provider if you develop any of the following in your mouth: pain, swelling, redness, ulcers.
Skin reactions. REVTORPYK can cause skin reactions, including severe rash. Limit time in the sun during treatment with REVTORPYK. Tell your healthcare provider right away if you develop a new rash.
High blood sugar levels (hyperglycemia). High blood sugar can occur with REVTORPYK and may be severe. Your healthcare provider will monitor your blood sugar levels before and during treatment with REVTORPYK. It is not known if REVTORPYK is safe in people with Type 1 diabetes or Type 2 diabetes that is not controlled. Tell your healthcare provider right away if you develop symptoms of high blood sugar, including:
The most common side effects of REVTORPYK when used with fulvestrant and palbociclib include:
The most common side effects of REVTORPYK when used with fulvestrant include:
REVTORPYK may affect fertility in females and males, which may affect the ability to have children. Talk to your healthcare provider if this is a concern for you.
Your healthcare provider may change your dose, temporarily stop or permanently stop treatment if you have serious side effects.
These are not all the possible side effects of REVTORPYK. Consult the Patient Information for other drugs used in combination for their side effects.
You are encouraged to report side effects to the FDA at 800-FDA-1088 or to 877-4-CELCUITY (877-423-5284).
Tell your healthcare provider about all of the medicines you take, including prescription or over-the-counter medicines, vitamins, and herbal supplements.
REVTORPYK is a prescription medicine used in combination with the medicine fulvestrant, with or without the medicine palbociclib, to treat adults who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that:
It is not known if REVTORPYK is safe and effective in children.
Please see full Prescribing Information, and read Important Facts for REVTORPYK at REVTORPYK.com
REVTORPYK may cause serious side effects, including:
Mouth sores (stomatitis). REVTORPYK can cause severe mouth sores, including mouth ulcers. Your healthcare provider will prescribe an alcohol-free, steroid-containing mouthwash to help prevent and treat mouth sores. Use as instructed by your healthcare provider. Do not eat or drink for at least 1 hour after using the steroid-containing mouthwash.
Tell your healthcare provider if you develop any of the following in your mouth: pain, swelling, redness, ulcers.
Skin reactions. REVTORPYK can cause skin reactions, including severe rash. Limit time in the sun during treatment with REVTORPYK. Tell your healthcare provider right away if you develop a new rash.
High blood sugar levels (hyperglycemia). High blood sugar can occur with REVTORPYK and may be severe. Your healthcare provider will monitor your blood sugar levels before and during treatment with REVTORPYK. It is not known if REVTORPYK is safe in people with Type 1 diabetes or Type 2 diabetes that is not controlled. Tell your healthcare provider right away if you develop symptoms of high blood sugar, including:
The most common side effects of REVTORPYK when used with fulvestrant and palbociclib include:
The most common side effects of REVTORPYK when used with fulvestrant include:
REVTORPYK may affect fertility in females and males, which may affect the ability to have children. Talk to your healthcare provider if this is a concern for you.
Your healthcare provider may change your dose, temporarily stop or permanently stop treatment if you have serious side effects.
These are not all the possible side effects of REVTORPYK. Consult the Patient Information for other drugs used in combination for their side effects.
You are encouraged to report side effects to the FDA at 800-FDA-1088 or to 877-4-CELCUITY (877-423-5284).
Tell your healthcare provider about all of the medicines you take, including prescription or over-the-counter medicines, vitamins, and herbal supplements.
REVTORPYK is a prescription medicine used in combination with the medicine fulvestrant, with or without the medicine palbociclib, to treat adults who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that:
It is not known if REVTORPYK is safe and effective in children.
Please see full Prescribing Information, and read Important Facts for REVTORPYK at REVTORPYK.com
HER2-=human epidermal growth factor receptor 2 negative; HR+=hormone receptor positive; PIK3CA=phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha.
